ArticleAdvances in therapy2019

Safety and Effectiveness of Ipragliflozin for Type 2 Diabetes in Japan: 12-Month Interim Results of the STELLA-LONG TERM Post-Marketing Surveillance Study.

Ichiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.